Drug Database
Back to search

Netherlands· NL-be64722a779b

Hydroxocobalamine HCl CF 0,5 mg/ml, oplossing voor injectie

A hydroxocobalamin product containing hydroxocobalaminehydrochloride, registered in Netherlands by Centrafarm B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC B03BA03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedHydroxocobalamine HCl CF 0,5 mg/ml, o…ATCB03BA03REGISTER NO.NL-be64722a779bPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hydroxocobalaminehydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Hydroxocobalamin is registered in 11 of 19 countries.

Countries holding a registration under ATC B03BA03 (hydroxocobalamin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search hydroxocobalamin products by name

Hydroxocobalamin · ATC B03BA03

11 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
HYDROXOCOBALAMINEHYDROCHLORIDE
Manufacturer
Centrafarm B.V.
Country
Netherlands (NL)
ATC code
B03BA03
ATC class
Hydroxocobalamin
Defined daily dose
20 mcg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    50830

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

40 interactions on record for hydroxocobalamin.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check hydroxocobalamin against other medicinesHow interaction checks work

Hydroxocobalamin · interactions on record

40 records

  • 2 moderate
  • 38 info

Most severe, free to view

  • ChloramphenicolJ01BA01moderate
  • Arsenic trioxideL01XX27moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Hydroxocobalamin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hydroxocobalamin products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Erycytol Depot
  • Belgium · Hydroxocobalamine Acetate Sterop
  • Cyprus · Articlox
  • Germany · Depogamma, Lophakomp-B 12-Depot
  • Denmark · Cohemin, Hydroxocobalamin Alternova
  • Spain · Hidroxocobalamina Basi, Megamilbedoce
  • Finland · Cohemin, Hydroxocobalamin G.L. Pharma
  • France · Dodecavit, Novobedouze
  • United Kingdom (Northern Ireland) · Cobalin-H, Hydroxocobalamin Accord Healthcare
  • Greece · Articlox
  • Ireland · Hydroxocobalamin G.L. Pharma, Hydroxy-Vit
  • Iceland · Cyanokit, Hydroxocobalamin G.L. Pharma
  • Italy · Neo Cytamen
  • Liechtenstein · Cyanokit
  • Malta · Articlox
  • Norway · Cyanokit, Hydroxocobalamin Basi
  • Portugal · Hidroxocobalamina Basi
  • Sweden · Hydroxocobalamin Alternova, Hydroxocobalamin G.L. Pharma
  • Slovenia · Hidroksokobalamin Orion

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7581da54-d024-4870-9cbd-f017f66c817f
GET /v1/drugs/7581da54-d024-4870-9cbd-f017f66c817f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h50830_smpc.pdf",
  "strength": null,
  "atc_label": "Hydroxocobalamin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg50830",
  "excipients": [
    "AZIJNZUUR (E 260), GECONCENTREERD",
    "BENZYLALCOHOL (E 1519)",
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "HYDROXOCOBALAMINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h50830.pdf",
  "authorised_at": "1992/12/31",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "50830",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about hydroxocobalamin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console